Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (12): 1347-1353.doi: 10.12092/j.issn.1009-2501.2022.12.004

Previous Articles     Next Articles

Research progress of ketamine psychomimetic symptoms and reward mechanism

YANG Hang1, LU Fangzhou2, YANG Chun1, ZHU Wei1   

  1. 1The First Clinical College of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu, China; 2Department of Anesthesia and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Received:2022-09-01 Revised:2022-12-21 Online:2022-12-26 Published:2023-01-13

Abstract: Ketamine is a non-selective N-methyl-D-aspartic acid (NMDA) receptor antagonist. Ketamine plays a significant role in the treatment and research of neuropsychiatric diseases in recent years. The neural mechanism of ketamine psychogenic effects and reward pathway remains to be perfected, which may be closely related to a variety of neurons and pathways in the brain. This paper intends to review the relevant studies at home and abroad, and try to integrate the known neural mechanisms and put forward reasonable hypotheses.

Key words: ketamine, psychomimetic symptoms, reward, neural mechanism, drug dependence

CLC Number: